Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A7

    
• • ·Information for Authors

    Page :A8

    
• • ·Information for Authors

    Page :A9

    
• • ·Information for Readers

    Page :A10

    

• Editorial

  • ·Coronary artery imaging with multidetector computed tomography: A call for an evidence-based, multidisciplinary approach

    Page :945-948

    Paul Schoenhagen, Arthur E. Stillman, Mario J. Garcia, Sandra S. Halliburton, E. Murat Tuzcu, Steven E. Nissen, Michael T. Modic, Bruce W. Lytle, Eric J. Topol, Richard D. White

    Résumé Résumé Plan Plan

• Trial Design

  • ·Management of elderly patients with congestive heart failure—Design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)

    Page :949-955

    Hans Peter Brunner–La Rocca, Peter Theo Buser, Ruth Schindler, Alain Bernheim, Peter Rickenbacher, Matthias Pfisterer, for the TIME-CHF-Investigators c

    Résumé Résumé Plan Plan  
  • ·The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

    Page :956-961

    Rebecca Brown Fountain, David R. Holmes, Krishnaswamy Chandrasekaran, Douglas Packer, Samuel Asirvatham, Robert Van Tassel, Zoltan Turi

    Plan Plan  

• Results of Expert Meetings

  • ·24-Hour ambulatory blood pressure monitoring

    Page :962-968

    J. Conor O'Shea, Robert M. Califf

    Plan Plan

• Clinical Investigations

  • ·Missed opportunities in the secondary prevention of myocardial infarction: An assessment of the effects of statin underprescribing on mortality

    Page :969-975

    Peter C. Austin, Muhammad M. Mamdani, David N. Juurlink, David A. Alter, Jack V. Tu

    Résumé Résumé Plan Plan  
  • ·Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II

    Page :975.e1

    Christie M. Ballantyne, Marcelo Bertolami, Hugo Ricardo Hernandez Garcia, Daniel Nul, Evan A. Stein, Pierre Theroux, Robert Weiss, Valerie A. Cain, Joel S. Raichlen

    Résumé Résumé Plan Plan  
  • ·Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: Analysis of the Orbofiban in Patients with Unstable coronary Syndromes–Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial

    Page :976.e1

    Shaul Atar, Christopher P. Cannon, Sabina A. Murphy, Salvatore Rosanio, Barry F. Uretsky, Yochai Birnbaum

    Résumé Résumé Plan Plan  
  • ·Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers

    Page :976.e7

    Juhana Karha, Vivek Rajagopal, Kandice Kottke-Marchant, Deepak L. Bhatt

    Résumé Résumé Plan Plan  
  • ·Periodontal infections cause changes in traditional and novel cardiovascular risk factors: Results from a randomized controlled clinical trial

    Page :977-984

    Francesco D'Aiuto, Mohamed Parkar, Luigi Nibali, Jean Suvan, Jan Lessem, Maurizio S. Tonetti

    Résumé Résumé Plan Plan  
  • ·Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial

    Page :985-991

    John J.V. McMurray, James B. Young, Mark E. Dunlap, Christopher B. Granger, James Hainer, Eric L. Michelson, Steven Earle, Bertil Olofsson, Jan Östergren, Salim Yusuf, Karl Swedberg, Marc A. Pfeffer, on behalf of the CHARM Investigators

    Résumé Résumé Plan Plan  
  • ·Multifaceted intervention to promote ?-blocker use in heart failure

    Page :992-998

    Nancy M. Allen LaPointe, Elizabeth R. DeLong, Anita Chen, Bradley G. Hammill, Lawrence H. Muhlbaier, Robert M. Califf, Judith M. Kramer

    Résumé Résumé Plan Plan  
  • ·How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure : Results from the Breathing Not Properly Multinational Study

    Page :999-1005

    Lori B. Daniels, Paul Clopton, Vikas Bhalla, Padma Krishnaswamy, Richard M. Nowak, James McCord, Judd E. Hollander, Philippe Duc, Torbjørn Omland, Alan B. Storrow, William T. Abraham, Alan H.B. Wu, Philippe G. Steg, Arne Westheim, Cathrine Wold Knudsen, Alberto Perez, Radmila Kazanegra, Howard C. Herrmann, Peter A. McCullough, Alan S. Maisel

    Résumé Résumé Plan Plan  
  • ·Gray zone BNP levels in heart failure patients in the emergency department: Results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study

    Page :1006-1011

    Cynthia K. Brenden, Judd E. Hollander, David Guss, Peter A. McCullough, Richard Nowak, Gary Green, Mitchell Saltzberg, Stefanie R. Ellison, Meenakshi Awasthi Bhalla, Vikas Bhalla, Paul Clopton, Robert Jesse, Alan S. Maisel, for the REDHOT Investigators

    Résumé Résumé Plan Plan  
  • ·Low prevalence of B-type natriuretic peptide levels <100 pg/mL in patients with heart failure at hospital discharge

    Page :1012.e1

    Jochem Hogenhuis, Adriaan A. Voors, Tiny Jaarsma, Hans L. Hillege, Arno W. Hoes, Dirk J. van Veldhuisen

    Résumé Résumé Plan Plan  
  • ·Intrafamilial variability of noncompaction of the ventricular myocardium

    Page :1012.e7

    Mark T. Johnson, Shaoxiong Zhang, Robert Gilkeson, Rebecca Ameduri, Ernest Siwik, Chandrakant R. Patel, Oleg Chebotarev, Alexander B. Kenton, Karla R. Bowles, Jeffrey A. Towbin, Nathaniel H. Robin, Frank Brozovich, Brian D. Hoit

    Résumé Résumé Plan Plan  
  • ·Hospital cost effect of a heart failure disease management program: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial

    Page :1013-1018

    Douglas Gregory, Carey Kimmelstiel, Kathleen Perry, Amay Parikh, Varda Konstam, Marvin A. Konstam

    Résumé Résumé Plan Plan  
  • ·Sirolimus-eluting coronary stents in small vessels

    Page :1019.e1

    Bernhard Meier, Eduardo Sousa, Giulio Guagliumi, Frank Van den Branden, Ehud Grenadier, Stephan Windecker, Hans te Riele, Vasilis Voudris, Hélène Eltchaninoff, Bo Lindvall, David Snead, Aly Talen, for the SVELTE Study Group

    Résumé Résumé Plan Plan
  • ·Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

    Page :1020-1024

    Gastón A. Rodriguez-Granillo, Eugène P. Mc Fadden, Marco Valgimigli, Carlos A.G. van Mieghem, Evelyn Regar, Pim J. de Feyter, Patrick W. Serruys

    Résumé Résumé Plan Plan  
  • ·In vivo relationship between compositional and mechanical imaging of coronary arteries : Insights from intravascular ultrasound radiofrequency data analysis

    Page :1025.e1

    Gastón A. Rodriguez-Granillo, Héctor M. García-García, Marco Valgimigli, Johannes A. Schaar, Ravindra Pawar, William J. van der Giessen, Evelyn Regar, Antonius F.W. van der Steen, Pim J. de Feyter, Patrick W. Serruys

    Résumé Résumé Plan Plan  
  • ·Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention

    Page :1026-1031

    Jeffrey S. Berger, Timothy A. Sanborn, Warren Sherman, David L. Brown

    Résumé Résumé Plan Plan  
  • ·Preprocedural statin use is associated with a reduced hazard of postprocedural myonecrosis in patients undergoing rotational atherectomy—a propensity-adjusted analysis

    Page :1031.e1

    Hitinder S. Gurm, Yuri Breitbart, Deepak Vivekanathan, Michael H. Yen, Robert Fathi, Khaled M. Ziada, Patrick L. Whitlow, Stephen G. Ellis

    Résumé Résumé Plan Plan  
  • ·Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: A subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

    Page :1032.e1

    Matthews Chacko, A. Michael Lincoff, Katherine E. Wolski, David J. Cohen, John A. Bittl, Alexandra J. Lansky, Yoshihiro Tsuchiya, Amadeo Betriu, Michael H. Yen, Derek P. Chew, Leslie Cho, Eric J. Topol

    Résumé Résumé Plan Plan  
  • ·Acetylcysteine In Diabetes (AID): A randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics

    Page :1032.e9

    Louis C. Coyle, Antonio Rodriguez, Robert E. Jeschke, Anabela Simon-Lee, Kevin C. Abbott, Allen J. Taylor

    Résumé Résumé Plan Plan  
  • ·Effects of a statewide physician-led quality-improvement program on the quality of cardiac care

    Page :1033-1042

    J. Richard Goss, Charles Maynard, Gabriel S. Aldea, Miriam Marcus-Smith, Richard W. Whitten, Gilbert Johnston, Richard C. Phillips, Mark Reisman, Ann Kelley, Richard P. Anderson, for the Clinical Outcomes Assessment Program (COAP)

    Résumé Résumé Plan Plan  
  • ·Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm

    Page :1043-1049

    Edward L.C. Pritchett, Peter Kowey, Stuart Connolly, Richard L. Page, Charles Kerr, William E. Wilkinson, For the A-COMET-I Investigators

    Résumé Résumé Plan Plan  
  • ·Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy : The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study

    Page :1050-1058

    Giuseppe Boriani, Cord Paul Müller, Karl Heinz Seidl, Rainer Grove, Jürgen Vogt, Wilfried Danschel, Andreas Schuchert, Pierre Djiane, Mauro Biffi, Thorsten Becker, Christophe Bailleul, Hans Joachim Trappe, for the Resynchronization for the HemodYnamic Treatment for Heart Failure Management II (RHYTHM II) investigators

    Résumé Résumé Plan Plan  
  • ·Diagnostic conclusions from the EASI-derived 12-lead electrocardiogram as compared with the standard 12-lead electrocardiogram in children

    Page :1059-1064

    Annika Welinder, Dirk Q. Feild, Jerome Liebman, Charles Maynard, Galen S. Wagner, Göran Wettrell, Olle Pahlm

    Résumé Résumé Plan Plan  
  • ·Comparison of long-term mortality across the spectrum of acute coronary syndromes

    Page :1065-1071

    Larry A. Allen, Christopher J. O'Donnell, Carlos A. Camargo, Robert P. Giugliano, Donald M. Lloyd-Jones

    Résumé Résumé Plan Plan  
  • ·Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients—Findings From the International Verapamil SR/Trandolapril Study (INVEST)

    Page :1072-1079

    Rhonda M. Cooper-DeHoff, Juan M. Aranda, Efrain Gaxiola, Jose L. Cangiano, David Garcia-Barreto, C. Richard Conti, Ann Hewkin, Carl J. Pepine, for the INVEST Investigators

    Résumé Résumé Plan Plan  
  • ·Electrocardiographic abnormalities predict deaths from cardiovascular disease and ischemic heart disease in Pima Indians with type 2 diabetes

    Page :1080-1086

    Aida Jimenez-Corona, Robert G. Nelson, Maurice L. Sievers, William C. Knowler, Robert L. Hanson, Peter H. Bennett

    Résumé Résumé Plan Plan  
  • ·Increased cardiovascular risk associated with diabetes in Dallas County

    Page :1087-1093

    Sandeep R. Das, Patrice A.C. Vaeth, Harold G. Stanek, James A. de Lemos, Robert L. Dobbins, Darren K. McGuire

    Résumé Résumé Plan Plan  
  • ·NT–probrain natriuretic peptide predicts complexity and severity of the coronary lesions in patients with non–ST-elevation acute coronary syndromes

    Page :1093.e1

    José Luis Navarro Estrada, Fernando Rubinstein, Maria Cecilia Bahit, Florencia Rolandi, Diego Perez de Arenaza, Jose M. Gabay, Jose Alvarez, Ricardo Sarmiento, Carlos Rojas Matas, Carlos Sztejfman, Alejandro Tettamanzi, Raul de Miguel, Luis Guzman, on behalf of PACS Investigators

    Résumé Résumé Plan Plan  
  • ·Effect of comorbidity on coronary reperfusion strategy and long-term mortality after acute myocardial infarction

    Page :1094-1100

    Daniela Balzi, Alessandro Barchielli, Eva Buiatti, Caterina Franceschini, Rinaldo Lavecchia, Matteo Monami, Giovanni Maria Santoro, Nazario Carrabba, Massimo Margheri, Iacopo Olivotto, Gian Franco Gensini, Niccolò Marchionni, for the AMI-Florence Working Group h

    Résumé Résumé Plan Plan  
  • ·Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction

    Page :1101.e1

    Erdal Cavusoglu, Cyril Ruwende, Vineet Chopra, Sunitha Yanamadala, Calvin Eng, Luther T. Clark, David J. Pinsky, Jonathan D. Marmur

    Résumé Résumé Plan Plan  
  • ·Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome

    Page :1102-1107

    Jaap Jan J. Smit, Nicolette M.S.K.J. Ernst, Robbert J. Slingerland, J.J. Evelien Kolkman, Harry Suryapranata, Jan C.A. Hoorntje, Jan Henk Dambrink, Jan Paul Ottervanger, A.T. Marcel Gosselink, Menko Jan de Boer, Arnoud W.J. van't Hof, On-TIME study group

    Résumé Résumé Plan Plan  
  • ·Handgrip-enhanced myocardial fractional flow reserve for assessment of coronary artery stenoses

    Page :1107.e1

    Demosthenes G. Katritsis, Socrates Korovesis, Evangelia Karvouni, Eleftherios Giazitzoglou, Ilias Karabinos, Efthalia Tzanalaridou, Demosthenes Panagiotakos, Michael M. Webb-Peploe

    Résumé Résumé Plan Plan  
  • ·Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts

    Page :1108-1114

    Anne Kaltoft, Morten Bøttcher, Niels Peter Sand, Michael Rehling, Niels Trolle Andersen, Felix Zijlstra, Torsten Toftegaard Nielsen

    Résumé Résumé Plan Plan  
  • ·Elevated plasma N-terminal pro–brain natriuretic peptide levels in acute ischemic stroke

    Page :1115-1122

    Kenan Iltumur, Aziz Karabulut, Ismail Apak, Ufuk Aluclu, Zuhal Ariturk, Nizamettin Toprak

    Résumé Résumé Plan Plan  
  • ·Depression symptoms predict heart rate recovery after treadmill stress testing

    Page :1122.e1

    Joel W. Hughes, Elizabeth Casey, Faith Luyster, Vicki H. Doe, Donna Waechter, James Rosneck, Richard Josephson

    Résumé Résumé Plan Plan  
  • ·Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)

    Page :1123-1128

    James B. Froehlich, Debabrata Mukherjee, Alvaro Avezum, Andrzej Budaj, Eva M. Kline-Rogers, José López-Sendón, Jeanna Allegrone, Kim A. Eagle, Rajendra H. Mehta, Robert J. Goldberg, for the GRACE Investigators

    Résumé Résumé Plan Plan  
  • ·Assessment of patent foramen ovale in carcinoid heart disease

    Page :1129.e1

    Nicolas Mansencal, Emmanuel Mitry, Jean-François Forissier, Fabrice Martin, Alban Redheuil, Céline Lepère, Jean-Christian Farcot, Thierry Joseph, Pascal Lacombe, Philippe Rougier, Olivier Dubourg

    Résumé Résumé Plan Plan
  • ·Analysis of factors related to successful transcatheter closure of secundum atrial septal defects using the HELEX septal occluder

    Page :1129.e7

    Larry A. Latson, Thomas K. Jones, Joth Jacobson, Evan Zahn, John F. Rhodes

    Résumé Résumé Plan Plan

• Letters to the Editor

  • ·Letter to the Editor

    Page :e1

    Ira D. Galin, Donald A. Smith

    
  • ·The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial (Am J Heart 2005;150:189-92)

    Page :e3

    Atul Aggarwal

    
  • ·Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting

    Page :e5

    Atul Aggarwal

    
  • ·Response to Aggarwal, Inflammatory response after intervention assesed by serial C-reactive protein measurements correlates with resterosis in patients with coronary stenting (Am Heart J 2005;150:344-50)

    Page :e7

    Alban Dibra, Albert Schömig, Adnan Kastrati

    
  • ·Letter to the Editor

    Page :e9

    Niels P. Riksen, Paul Smits, Gerard A. Rongen

    
  • ·What mediated the beneficial roles of methotrexate in chronic heart failure?

    Page :e11

    Kaizheng Gong, Zhengang Zhang, Guojie Song

    
  • ·Schizophrenia and increased risk of cardiovascular disease

    Page :e13

    Paul Mackin, Hamish M^cAllister-Williams